ZA201201570B - A method of crystallization of (s)-n-methyl-3-1(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine) - Google Patents
A method of crystallization of (s)-n-methyl-3-1(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)Info
- Publication number
- ZA201201570B ZA201201570B ZA2012/01570A ZA201201570A ZA201201570B ZA 201201570 B ZA201201570 B ZA 201201570B ZA 2012/01570 A ZA2012/01570 A ZA 2012/01570A ZA 201201570 A ZA201201570 A ZA 201201570A ZA 201201570 B ZA201201570 B ZA 201201570B
- Authority
- ZA
- South Africa
- Prior art keywords
- duloxetine
- naphthyloxy
- thienyl
- crystallization
- methyl
- Prior art date
Links
- ZEUITGRIYCTCEM-KRWDZBQOSA-N (S)-duloxetine Chemical compound C1([C@@H](OC=2C3=CC=CC=C3C=CC=2)CCNC)=CC=CS1 ZEUITGRIYCTCEM-KRWDZBQOSA-N 0.000 title 1
- 238000002425 crystallisation Methods 0.000 title 1
- 230000008025 crystallization Effects 0.000 title 1
- 229960002866 duloxetine Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2009-584A CZ304602B6 (cs) | 2009-09-02 | 2009-09-02 | Způsob krystalizace hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (hydrochloridu duloxetinu) |
| PCT/CZ2010/000099 WO2011026449A1 (en) | 2009-09-02 | 2010-09-02 | A method of crystallization of (s)-n-methyl-3-(1-naphthyloxy)-3- (2-thienyl)propylamine hydrochloride (duloxetine) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201201570B true ZA201201570B (en) | 2013-08-28 |
Family
ID=43413356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2012/01570A ZA201201570B (en) | 2009-09-02 | 2012-03-01 | A method of crystallization of (s)-n-methyl-3-1(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine) |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2473497A1 (cs) |
| JP (1) | JP2013503823A (cs) |
| KR (1) | KR20120047262A (cs) |
| CN (1) | CN102482254A (cs) |
| BR (1) | BR112012004862A2 (cs) |
| CZ (1) | CZ304602B6 (cs) |
| EA (1) | EA021528B1 (cs) |
| IL (1) | IL218329A0 (cs) |
| MX (1) | MX2012002621A (cs) |
| WO (1) | WO2011026449A1 (cs) |
| ZA (1) | ZA201201570B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103626735A (zh) * | 2012-08-28 | 2014-03-12 | 石药集团中奇制药技术（石家庄）有限公司 | 一种盐酸度洛西汀晶型及其制备方法 |
| CN104478849A (zh) * | 2014-02-14 | 2015-04-01 | 广东东阳光药业有限公司 | 制备去甲肾上腺素再摄取双重抑制剂的方法 |
| CN106265528A (zh) * | 2015-05-12 | 2017-01-04 | 法德生技药品股份有限公司 | 制备药物凝集体的方法 |
| JP2016222628A (ja) * | 2015-06-03 | 2016-12-28 | 株式会社トクヤマ | デュロキセチン塩酸塩の製造方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR880007433A (ko) | 1986-12-22 | 1988-08-27 | 메리 앤 터커 | 3-아릴옥시-3-치환된 프로판아민 |
| US5362886A (en) | 1993-10-12 | 1994-11-08 | Eli Lilly And Company | Asymmetric synthesis |
| DE10212301A1 (de) | 2002-03-20 | 2003-10-02 | Bayer Ag | Verfahren zur Herstellung von Aryl-aminopropanolen |
| KR101027358B1 (ko) | 2002-07-09 | 2011-04-11 | 론자 아게 | Ｎ-일치환 β-아미노 알코올의 제조 방법 |
| GB0410470D0 (en) * | 2004-05-11 | 2004-06-16 | Cipla Ltd | Pharmaceutical compound and polymorphs thereof |
| CZ297560B6 (cs) * | 2004-10-26 | 2007-02-07 | Zentiva, A. S. | Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (duloxetinu) |
| TW200639162A (en) * | 2005-03-14 | 2006-11-16 | Teva Pharma | Pure duloxetine hydrochloride |
| EP1820800A1 (en) * | 2006-02-17 | 2007-08-22 | KRKA, tovarna zdravil, d.d., Novo mesto | Crystalline forms of duloxetine hydrochloride and processes for their preparation |
| GB0612508D0 (en) * | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
| GB0612509D0 (en) * | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
| CZ300116B6 (cs) * | 2006-12-05 | 2009-02-11 | Zentiva, A. S. | Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu |
| US8269023B2 (en) * | 2007-03-05 | 2012-09-18 | Lupin Ltd. | Process for preparation of duloxetine hydrochloride |
-
2009
- 2009-09-02 CZ CZ2009-584A patent/CZ304602B6/cs not_active IP Right Cessation
-
2010
- 2010-09-02 JP JP2012527196A patent/JP2013503823A/ja active Pending
- 2010-09-02 CN CN2010800392370A patent/CN102482254A/zh active Pending
- 2010-09-02 BR BR112012004862A patent/BR112012004862A2/pt not_active IP Right Cessation
- 2010-09-02 EA EA201290127A patent/EA021528B1/ru not_active IP Right Cessation
- 2010-09-02 MX MX2012002621A patent/MX2012002621A/es not_active Application Discontinuation
- 2010-09-02 KR KR1020127004225A patent/KR20120047262A/ko not_active Withdrawn
- 2010-09-02 EP EP10771629A patent/EP2473497A1/en not_active Withdrawn
- 2010-09-02 WO PCT/CZ2010/000099 patent/WO2011026449A1/en active Application Filing
-
2012
- 2012-02-27 IL IL218329A patent/IL218329A0/en unknown
- 2012-03-01 ZA ZA2012/01570A patent/ZA201201570B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120047262A (ko) | 2012-05-11 |
| EA021528B1 (ru) | 2015-07-30 |
| BR112012004862A2 (pt) | 2015-09-08 |
| EA201290127A1 (ru) | 2013-02-28 |
| EP2473497A1 (en) | 2012-07-11 |
| JP2013503823A (ja) | 2013-02-04 |
| MX2012002621A (es) | 2012-07-03 |
| IL218329A0 (en) | 2012-04-30 |
| CN102482254A (zh) | 2012-05-30 |
| CZ2009584A3 (cs) | 2011-03-09 |
| WO2011026449A1 (en) | 2011-03-10 |
| CZ304602B6 (cs) | 2014-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201203115B (en) | Method for producing a mouthpiece cover of a cigaratte | |
| PL2513434T3 (pl) | Jednostka krzywki do składanego wału krzywkowego | |
| IL230600A0 (en) | A method for producing a benzo[b]thiophene compound | |
| IL214023A0 (en) | Crystalline n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride | |
| GB2460070B (en) | A method of data delivery across a network | |
| IL208056A (en) | Method for estimating substrate model | |
| EP1976844A4 (en) | IMPROVED METHOD FOR PURE DULOXETIN HYDROCHLORIDE | |
| SG10201500190PA (en) | Method of making a contact lens | |
| PL2379299T3 (pl) | Sposób wypełniania osłony | |
| AP3169A (en) | A method of improved positioning | |
| GB2486609B (en) | Adjusting a transducer head for transferring data | |
| EP2465293A4 (en) | TRANSFER METHOD FOR MINIMIZING DATA TREATED TO A TARGET NODE | |
| ZA201400284B (en) | Method for manufacturing a confectionery shell | |
| EP2328815A4 (en) | IMAGE CAPTURE DEVICE | |
| IL232972A0 (en) | Production method for a nitrogen-containing heterocyclic compound | |
| ZA201201570B (en) | A method of crystallization of (s)-n-methyl-3-1(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine) | |
| GB0612508D0 (en) | Crystalline duloxetine hydrochloride | |
| IL191921A0 (en) | A novel process for the preparation of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate | |
| GB0700830D0 (en) | Crystalline duloxetine hydrochloride | |
| GB0612506D0 (en) | Crystalline duloxetine hydrochloride | |
| ZA201108919B (en) | Method for modifying a transfer case for a plurality of outputs | |
| EP2016066A4 (en) | PROCESS FOR PREPARING DULOXETINE | |
| GB0815458D0 (en) | Method of transferring timing information over packet network | |
| RS56798B1 (sr) | Metoda za verifikaciju ispravnog prenosa podataka u video memoriju | |
| WO2008093360A3 (en) | A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride |